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Controversy in public 
hospital reforms 
in China
On Jan 15, 2016, the National Health 
and Family Planning Commission 
of China reported its work plan for 
2016 at a press conference in Beijing, 
mentioning that it will expand the 
public hospital reform to 200 cities in 
China.1 The core part of the reform is 
to ban the price increase of drugs and 
materials, reduce the cost of medical 
examinations, and appropriately raise 
the price of medical services provided 
by physicians, such as surgery. 
However, under this circumstance, 
public hospitals in China are now in 
the dilemma of whether to choose 
reasonable hospital operational costs 
or public welfare. With the increasing 
demand for health-care services, 
the operational cost of hospitals 
will inevitably increase. For public 
hospitals, drug sales account for about 
40% of their revenue, and medical 
income (eg, from examinations, 
laboratory tests, and operations) 
brings in about 49%.2 With the ban 
on charging extra for drugs and 
materials, as well as the reduced cost 
of examinations, hospitals’ revenue is 
likely to reduce. Although the income 
from medical services will increase, 
this factor is far from enough to oﬀ set 
the operational cost, which will result 
in a great reduction in many public 
hospitals’ gross revenue, even leaving 
some hospitals at a financial loss. 
According to some health insurance 
policies, there are limits on how much 
a patient can spend on their treatment. 
If the total cost exceeds the limit, then 
the hospital might not get the balance 
from the health insurance department. 
Because of these health insurance 
issues, hospitals have no choice but 
to reduce the use of expensive but 
eﬀ ective drugs and materials. However, 
this move could compromise the 
quality of medical services.
The government’s subsidy accounts 
for only about 8% of public hospitals’ 
revenue, putting these institutions 
under great pressure.2 Public hospitals 
have to seek new ways to make a 
proﬁ t instead of only sticking to their 
public welfare goals. The government 
has lowered medical costs in response 
to public demand; however, the 
subsidy remains the same. To solve 
the dilemma hospitals are now facing, 
the government should increase 
the subsidy to a level that is enough 
to cover operational costs without 
damaging the medical staﬀ ’s initiative. 
Investment in health-care services 
takes up only about 6% of finance 
expenditure in China,2 compared with 
about 15% in developed countries. 
Additionally, the adjustment of the 
prices of medical services is lagging 
far behind the market prices. The 
mechanism of adjustment for these 
prices should be revisited. 
People could beneﬁ t a lot from the 
launch of the public hospitals reform. 
For public hospitals, it is not a simple 
choice of choosing survival of the 
organisation or public welfare. We 
should ﬁ nd balance between them. 
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